Key facts
- It has raised $990K.
- Notable investors include Michigan Rise, Red Cedar Ventures, U.S. Department of Health and Human Services, Western Michigan University.
- Status: Privately Held (backing).
- ·The complete investor list — 4 names
- ·Watchlist + deal alerts for Advertent Biotherapeutics
- ·The full record, as it builds
Funding rounds
No funding rounds for Advertent Biotherapeutics are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Advertent Biotherapeutics
Developer of biologic therapies intended to preserve muscle strength and mobility when muscle is damaged by genetic diseases, injury, or aging. The company offers biologic therapies based on growth factor biology research and muscle pathology expertise, enabling patients with muscle damage and degenerative muscle conditions to maintain muscle quality over time.
- Sector
- Healthcare
- HQ
- East Lansing, MI, United States
- Founded
- 2019
- Employees
- 4
- Website
- advertentbio.com/
- Ownership
- Privately Held (backing)
Advertent Biotherapeutics doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Advertent Biotherapeutics shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Advertent Biotherapeutics in its N-PORT filings yet. We sweep new filings monthly.